Sou Hu Cai Jing·2025-07-21 11:58Core Viewpoint - Spring Medical's stock closed at 19.88 yuan, with a PE ratio of 59.64 times, indicating a strong market position within the medical device industry [1] Company Summary - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, and PRP preparation kits [1] - The company achieved a revenue of 230 million yuan in Q1 2025, representing a year-on-year growth of 3.60%, and a net profit of 58.07 million yuan, with a year-on-year increase of 5.20% [1] - The gross profit margin for the latest quarter was reported at 66.69% [1] Industry Summary - The average PE ratio for the medical device industry is 52.71 times, with a median of 37.14 times, positioning Spring Medical above the industry average [2] - The total market capitalization of Spring Medical is 7.625 billion yuan [1][2] - As of Q1 2025, eight institutions hold shares in Spring Medical, with a total holding of 6.4251 million shares valued at 119 million yuan [1]